ActiTrexx

Description: ActiTrexx develops curative cellular therapies using activated Treg cells to prevent inflammatory reactions in GvHD, transplants & autoimmune diseases.

Country: Germany

Based in: Mainz

Founded: 2019

Funding Stage: Seed

Tags: ['Biotechnology Research', 'Cellular Therapy', 'Pharmaceutical Development']

Categories

Add insights to your inbox

We’ll send you content you’ll want to read- and put to use.

Details about how we process your information are available in our Privacy Policy.